Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alfred Castillo

Sports Medicine Brooklyn, NY Doctor of Osteopathy

NPI 1194098954 CMS profile 2636230

263 7Th Ave, Suite B, Brooklyn, NY 11215

Open in the dashboard

General payments

$3,269

124 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alfred Castillo of Brooklyn, NY is reported in the CMS Open Payments database as having received $3,269 across 124 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $610 25
2024 General $959 41
2023 General $960 26
2022 General $463 15
2021 General $51 3
2020 General $95 7
2019 General $130 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alfred Castillo
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Alfred Castillo were reported at $610. Among 250 Sports Medicine profiles paid that year, the median was $119 and the middle half received between $39 and $268.

Show as a table
Year Alfred Castillo Sports Medicine median Middle half National median
2019 $130 $125 $45–$345 $163
2020 $95 $96 $33–$311 $114
2021 $51 $113 $34–$344 $132
2022 $463 $100 $35–$293 $149
2023 $960 $100 $42–$324 $160
2024 $959 $139 $45–$319 $164
2025 $610 $119 $39–$268 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $697 27 payments
  2. Relievant Medsystems, Inc. $687 20 payments
  3. Nevro Corp. $308 9 payments
  4. AbbVie, Inc. $283 11 payments
  5. Ferring Pharmaceuticals Inc. $168 8 payments
  6. Endo Pharmaceuticals Inc. $153 11 payments
  7. Vertos Medical, Inc. $132 1 payment
  8. Xeris Pharmaceuticals, Inc. $92 4 payments
  9. Saluda Medical Americas, Inc. $73 2 payments
  10. Novo Nordisk Inc $66 3 payments
  11. Other $609 28 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,269 124 payments
Products named General payments · program years 2019–2025
  1. Intracept Pain $772 24 payments
  2. Intracept Pain $434 14 payments
  3. Intracept Pain $434 14 payments
  4. Intracept Pain $434 14 payments
  5. Intracept Pain $253 6 payments
  6. Senza $213 5 payments
  7. QULIPTA $170 6 payments
  8. EUFLEXXA $168 8 payments
  9. XIAFLEX $153 11 payments
  10. mild Device Kit $132 1 payment
  11. Other $1,281 55 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

264

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$1,451

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

0%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 161 $1,048
Methylprednisolone Generic 28 $136
Ibuprofen Generic 14 $117
Naproxen Generic 15 $85
Meloxicam Generic 46 $66

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$70,227

Of which drugs: $8,134

Medicare patients

290

Average age 74

Services billed

2,902

190 women, 100 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 70%
Ischemic heart disease 42%
Diabetes 27%
Osteoporosis 21%
Depression 20%
Chronic kidney disease 19%
COPD 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 50 2,211 $227

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
  • AbbVie, Inc. $33
$33 — —
GVOKE HYPOPEN
  • Xeris Pharmaceuticals, Inc. $24
$24 — —
RECORLEV
  • Xeris Pharmaceuticals, Inc. $23
$23 — —
Tlando
  • Verity Pharmaceuticals Inc. $19
$19 — —
MOVANTIK
  • Valinor Pharma, LLC $17
$17 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

124 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record